A Microphase-Separated Design toward an All-Round Ionic Hydrogel with Discriminable and Anti-Disturbance Multisensory Functions

Stretchable ionic hydrogels with superior all-round properties that can detect multimodal sensations with excellent discriminability and robustness against external disturbances are highly required for artificial electronic skinapplications. However, some critical material parameters exhibit intrinsic tradeoffs with each other for most ionic hydrogels. Here, a microphase-separated hydrogel is demonstrated by combining three strategies: (1) using of a low crosslinker/monomer ratio to obtain highly entangled polymer chains as the first network; (2) the introduction of zwitterions into the first network; (3) the synthesis of an ultrasoft polyelectrolyte as the second network. This all-round elastic ionic hydrogel exhibits a low Young's modulus (< 60 kPa), large stretchability (> 900%), high resilience (> 95%), unique strain-stiffening behavior, excellent fatigue tolerance, high ionic conductivity (> 2.0 S m⁻1), and anti-freezing capability, which have not been achieved before. These properties allow the ionic hydrogel to operate as a stretchable multimodal sensor that can detect and decouple multiple stimuli (temperature, pressure, and proximity) with excellent discriminability, high sensitivity, and strong sensing-robustness against strains or temperature perturbations. The ionic hydrogel sensor exhibits great potential for intelligent electronic skin applications such as reliable health monitoring and accurate object identification.

Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder

Obesity has emerged as one of the most prevalent chronic diseases worldwide. Our study was conducted to investigate the anti-obese potential of novel probiotic Bifidobacterium longum subsp. infantis FB3-14 (FB3-14) and the underlying molecular mechanisms in high-fat diet (HFD)-fed mice. The results demonstrated that an 8-week FB3-14 intervention significantly suppressed the HFD-induced body and fat weight gain and abnormal alterations of the serum lipid parameter, restoring the levels of cholesterol (4.29 mmol/L) and low-density lipoprotein cholesterol (3.42 mmol/L). FB3-14 treatment also attenuated adipocyte expansion, hepatic injury, and low-grade systemic inflammation and restored the expressions of lipid-metabolism-related genes, including Hsl, Leptin, and Adiponectin. Furthermore, FB3-14 was observed to reduce the Firmicutes/Bacteroidetes ratio in obese mice; increase the abundance of Akkermansia muciniphila, unclassified_Muribaculaceae, Lachnospiraceae_NK4A136_group, and Bifidobacterim; and upregulate G protein-coupled receptor41 associated with higher levels of butyric acid. These results indicate the protective effectiveness of FB3-14 in HFD-driven obesity and gut microbiota disorders, highlighting the promising potential of FB3-14 as a functional nutrition supplement.